- Home
- Equipment
- usa washington
- biomark
Refine by
Biomark Equipment Supplied In Usa Washington
5 equipment items found
Manufactured by:Phoresa, Inc. based inSeattle, WASHINGTON (USA)
Our technology uses an electric field and custom assay chemistry to concentrate target biomarkers at the capture test line. The highly concentrated sample results in lower detection limits and higher clinical sensitivity to aid in patient diagnosis for infectious diseases. Phoresa specializes in the design and development of high sensitivity immunoassays for infection ...
Manufactured by:SEngine Precision Medicine based inSeattle, WASHINGTON (USA)
SEngine Precision Medicine’s innovative approach brings diagnostics, drug discovery and proprietary algorithms together with our patient-derived 3D tumor organoids to identify translational biomarkers and develop new cancer-fighting drugs. ...
Manufactured by:Oasis Diagnostics based inVancouver, WASHINGTON (USA)
Pure•SAL was developed for the controlled and standardized collection of RNA or protein biomarkers from oral fluid specimens for subsequent stabilization and analysis in life science and research applications. The Pure•SAL Oral Specimen Collection Kit provides a simple non-invasive and rapid platform for isolating “liquid biopsy” specimens including cell ...
Manufactured by:Cancer Targeted Technology based inWoodinville, WASHINGTON (USA)
CTT1057 is an innovative 18F-labeled PET agent for prostate cancer that can be imaged within 2 hours of administration. CTT1057 will specifically and sensitively detect cancer that has escaped from the prostate as well as distant metastatic disease including bone metastases with greater precision and resolution than current standard of care. With uncertainty in how to interpret PSA test results, ...
Manufactured by:Cancer Targeted Technology based inWoodinville, WASHINGTON (USA)
CTT’s lead therapeutic product, CTT1403, is a PSMA-targeted 177Lu-labeled agent for prostate cancer that can has superior binding characteristics, long circulation half-life, enhanced tumor uptake and unparalleled anti-tumor efficacy. CTT1403 will specifically deliver the radionuclide, 177Lu, minimizing toxic side effects and more effectively treating metastatic prostate cancer and other ...